Losing muscle slows your metabolism permanently, makes you more likely to regain weight after stopping medication, and robs you of the strength and energy gains that make weight loss genuinely life-changing
The positive feedback patterns Patients consistently praise several aspects of the MEDVi experience
People on the highest dose of orforglipron lost on average around 10% of their baseline body weight, for instance, compared to the 2.5% average weight loss seen in those taking a placebo
Eli Lilly's latest data release follows the company's earlier findings, released in early August, that showed that trial participants who are overweight or have obesity lost an average of 27 pounds or about 12.4% of their body weight after taking Eli Lilly's oral daily GLP-1 pill -- orforglipron -- for at least 72 weeks
Please do not stop, adjust, or modify your dose of any prescribed medications without the direct supervision of your healthcare practitioner
GLP-1 and Thyroid Cancer The biggest cancer-related worry involves medullary thyroid carcinoma, or MTC
